trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['trastuzumab deruxtecan', 'nsclc', 'sclc', 'lcsm,(-blcsm)']
trastuzumab deruxtecan at reduced dose maintains efficacy her2-mutated nsclc #lcsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.